John A. Scarlett - Jun 6, 2024 Form 4 Insider Report for GERON CORP (GERN)

Role
Chairman, President and CEO, Director
Signature
/s/ Scott A. Samuels for John A. Scarlett
Stock symbol
GERN
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:10 PM
Previous filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GERN Employee Stock Option (right to buy) Award $0 +1M $0.00 1M Jun 6, 2024 Common Stock 1M $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance-based stock option granted on November 7, 2018 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.